Sluggish exports to regulated markets to cap pharma revenue growth this fiscal: CRISIL EP News Bureau Aug 24, 2022 Low-leveraged balance sheets to keep credit profiles stable
Taking India beyond ‘Pharmacy of the World’ Viveka Roychowdhury May 2, 2022 A policy to incentivise pharma R&D is crucial as there are already signs that pharma R&D dives when revenues dip